Sandbox: Difference between revisions
Jump to navigation
Jump to search
(Blanked the page) |
No edit summary |
||
| Line 1: | Line 1: | ||
* The following are discussed in more detail in other sections of the labeling: | |||
:* Use in elderly patients with dementia-related [[psychosis]] | |||
:* Suicidal thoughts and behaviors in adolescents and young adults | |||
:* [[Neuroleptic malignant syndrome]] (NMS) | |||
:* [[Tardive dyskinesia]] | |||
:* Metabolic changes | |||
:* [[Orthostatic hypotension]] | |||
:* [[Leukopenia]], [[neutropenia]], and [[agranulocytosis]] | |||
:* [[Seizures]]/[[convulsions]] | |||
:* Potential for cognitive and motor impairmen | |||
:* Body temperature regulation | |||
:* Suicide | |||
:* [[Dysphagia]] | |||
:* Use in patients with concomitant illness | |||
Revision as of 14:53, 25 July 2014
- The following are discussed in more detail in other sections of the labeling:
- Use in elderly patients with dementia-related psychosis
- Suicidal thoughts and behaviors in adolescents and young adults
- Neuroleptic malignant syndrome (NMS)
- Tardive dyskinesia
- Metabolic changes
- Orthostatic hypotension
- Leukopenia, neutropenia, and agranulocytosis
- Seizures/convulsions
- Potential for cognitive and motor impairmen
- Body temperature regulation
- Suicide
- Dysphagia
- Use in patients with concomitant illness